Cross-Sector entity
Roundup is most often covered alongside Bayer AG, which appears in 3 of these 5 stories. Across a 133-day span, the pace is roughly 0.3 stories per week. The busiest single day carried 2. The clearest coverage concentration is court-decisions: 2 of 5 stories, with the rest divided among 3 other categories.
5 verified stories tracked
Last mentioned: Jun 30, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 20 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Roundup is most often covered alongside Bayer AG, which appears in 3 of these 5 stories. Across a 133-day span, the pace is roughly 0.3 stories per week. The busiest single day carried 2. The clearest coverage concentration is court-decisions: 2 of 5 stories, with the rest divided among 3 other categories. Negative sentiment appears in 40% of the tracked stories. Each carries 2 original sources on average. We currently track 5 Cross-Sector stories that mention Roundup, published between February 18, 2026 and June 30, 2026.
Computed from the 5 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Roundup. Shared-story counts are live from our verified record — not editorial picks.
End of Certainty Period
The 21-year structured resolution period is slated to conclude.
U.S. Supreme Court Rules 7-2 in Monsanto v. Durnell
The Court holds that FIFRA expressly preempts state-law failure-to-warn claims requiring warnings beyond EPA-approved labeling, reversing a $1M+ jury verdict.
$7.25B Settlement Announced
Bayer agrees to a new $7.25 billion deal with a 21-year certainty plan.
Future Claims Deal
Bayer reaches a $7.25 billion agreement to resolve future litigation over a 21-year period.
Initial $10B Settlement
Bayer announces a massive settlement to resolve current claims, but future liability remains.
IARC Reiterates Finding; EPA Maintains Position
IARC reaffirms its classification. EPA re-examines the issue but adheres to its stance that glyphosate is not likely to cause cancer.
First Major Verdict
A California jury awards $289M to a groundskeeper, sparking a wave of litigation.
Monsanto Acquisition
Bayer completes $63 billion acquisition of Monsanto, inheriting Roundup litigation.
IARC Classifies Glyphosate as Probably Carcinogenic
The International Agency for Research on Cancer states that glyphosate is probably carcinogenic to humans, prompting litigation.
The Supreme Court's 7-2 decision in Monsanto v. Durnell expressly preempts state failure-to-warn claims against pesticide labels approved by EPA. The ruling resolves a circuit split and provides a robust preemption defense for manufacturers, marking a significant shift in product liability litigation under FIFRA.
The U.S. Supreme Court ruled that FIFRA preempts state failure-to-warn claims against Bayer's Roundup, eliminating a massive source of litigation uncertainty. The 7-2 decision validates EPA's safety assessment of glyphosate and sharply reduces Bayer's outstanding tort exposure, potentially freeing up billions in capital for the biotech giant.
Source: National Law Review · National Law Review
The Supreme Court’s 7-2 decision in Monsanto v. Durnell holds that FIFRA preempts state failure-to-warn claims requiring cancer warnings beyond EPA-approved labels. The ruling overturns a $1M+ verdict and provides a powerful preemption defense for pesticide manufacturers facing over 100,000 personal injury lawsuits.
Source: National Law Review · National Law Review
Bayer has reached a definitive $7.25 billion settlement to resolve future Roundup litigation, implementing a 21-year framework designed to provide financial and legal certainty. The deal aims to move the German conglomerate past the glyphosate-related liabilities that have weighed on its valuation since the 2018 Monsanto acquisition.
Bayer has reached a $7.25 billion settlement agreement to resolve long-standing litigation surrounding its Roundup herbicide. The deal includes a 21-year framework designed to provide legal and financial certainty for the company following years of costly courtroom battles.
